Spots Global Cancer Trial Database for pancreatic carcinoma
Every month we try and update this database with for pancreatic carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics | NCT04905082 | Breast Carcinom... Colorectal Carc... Lung Carcinoma Malignant Solid... Ovarian Carcino... Pancreatic Carc... Prostate Carcin... | Best Practice Educational Int... Educational Int... Genomic Profile Survey Administ... | 18 Years - | City of Hope Medical Center | |
| Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies | NCT02807844 | Triple Negative... Pancreatic Carc... Melanoma Endometrial Car... | MCS110 PDR001 | 18 Years - | Novartis | |
| Pilot Study of Pancreatic Cancer Screening | NCT05058846 | Pancreatic Carc... | Biospecimen Col... Magnetic Resona... Magnetic Resona... Endoscopic ultr... Questionnaires | 18 Years - | University of California, San Francisco | |
| The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer | NCT03747588 | Pancreatic Carc... Surgery | Minimally-invas... Open pancreatic... | 18 Years - 75 Years | Peking Union Medical College Hospital | |
| Accelerated Recovery Pathway for Discharge After Surgery in Patients With Pancreatic Cancer | NCT02517268 | Pancreatic Carc... | Pancreaticoduod... | 18 Years - | Thomas Jefferson University | |
| A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma | NCT05193604 | Pancreatic Carc... | TQB2858 injecti... Anlotinib Hydro... Gemcitabine hyd... Paclitaxel for ... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Clinical Outcomes for Offering Genetic Testing in a Tiered Approach | NCT04902144 | Breast Carcinom... Colon Carcinoma Malignant Solid... Ovarian Carcino... Pancreatic Carc... Prostate Carcin... | Electronic Heal... Questionnaire A... Behavioral Inte... | 19 Years - 90 Years | Fred Hutchinson Cancer Center | |
| A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma | NCT05193604 | Pancreatic Carc... | TQB2858 injecti... Anlotinib Hydro... Gemcitabine hyd... Paclitaxel for ... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Concurrent Chemoradiotherapy Combined With Immunotherapy in Patients With Potentially Resectable Pancreatic Cancer | NCT05634564 | Pancreatic Carc... | Tislelizumab Gemcitabine Nab paclitaxel Hypofractionate... | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma | NCT05193604 | Pancreatic Carc... | TQB2858 injecti... Anlotinib Hydro... Gemcitabine hyd... Paclitaxel for ... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients | NCT02456051 | Diabetes Mellit... Diabetes Compli... Carcinoma, Panc... Pancreatic Neop... | 45 Years - 75 Years | University of Roma La Sapienza | ||
| A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors | NCT06172478 | Advanced Solid ... Melanoma Head and Neck C... Gastric Cancer Ovarian Carcino... Cervical Cancer Endometrial Can... Bladder Cancer Esophageal Canc... Pancreatic Carc... Prostate Cancer | HER3-DXd | 18 Years - | Daiichi Sankyo | |
| CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor | NCT02839954 | Hepatocellular ... Non-small Cell ... Pancreatic Carc... Triple-Negative... Malignant Gliom... Colorectal Carc... Gastric Carcino... | anti-MUC1 CAR-p... | 18 Years - | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | |
| Combined Stent Insertion and HIFU Ablation for Pancreatic Carcinoma With Biliary Obstruction | NCT03962478 | Pancreatic Carc... Biliary Obstruc... | biliary stent a... biliary stent | 18 Years - 80 Years | Xuzhou Central Hospital | |
| Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery | NCT03745794 | Pancreatic Carc... | Best Practice Quadratus Lumbo... Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial | NCT05554367 | Malignant Solid... Ovarian Low Gra... Pancreatic Carc... Stage IV Ovaria... Stage IV Pancre... | Binimetinib Biopsy Biospecimen Col... Bone Scan Computed Tomogr... Magnetic Resona... Palbociclib | 18 Years - | National Cancer Institute (NCI) | |
| AG Combined With Immunotherapy and SBRT in Patients With Potentially Resectable Pancreatic Cancer | NCT06080854 | Pancreatic Carc... | Toripalimab Gemcitabine Nab paclitaxel SBRT | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Pancreatic Cancer Detection Consortium | NCT06388967 | Pancreatic Canc... Pancreatic Carc... Pancreatic Aden... Pancreatic Duct... Pancreatic Neop... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... | PANcreatic canc... | 18 Years - | City of Hope Medical Center | |
| Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies | NCT02807844 | Triple Negative... Pancreatic Carc... Melanoma Endometrial Car... | MCS110 PDR001 | 18 Years - | Novartis | |
| A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer | NCT03899649 | Stage III Pancr... | SOC NanoKnife Syste... | 18 Years - | Angiodynamics, Inc. | |
| Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Pancreatic Cancer | NCT03645148 | Pancreatic Canc... Pancreatic Carc... | iNeo-Vac-P01 GM-CSF | 18 Years - 70 Years | Zhejiang Provincial People's Hospital | |
| A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma | NCT05193604 | Pancreatic Carc... | TQB2858 injecti... Anlotinib Hydro... Gemcitabine hyd... Paclitaxel for ... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) | NCT05642962 | Metastatic Panc... Metastatic Panc... Metastatic Panc... Metastatic Panc... Pancreatic Carc... Pancreatic Carc... Pancreatic Carc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... PDAC PDAC - Pancreat... | Pertzye | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer | NCT03711890 | Pancreatic Carc... Pancreatic Intr... | Optical Coheren... Therapeutic Con... Laboratory Eval... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| L-CARnitine in the Palliative Treatment of Advanced PANcreatic Cancer (CARPAN) | NCT01330823 | Pancreatic Carc... | L-Carnitine Placebo | - | University Medicine Greifswald | |
| Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive | NCT01262040 | Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Canc... Gastrointestina... Pancreatic Carc... Lung Cancer Esophageal Carc... | Narrow Band Ima... | 19 Years - | Memorial Sloan Kettering Cancer Center | |
| Use Of Indocyanine Green In Pancreas Surgery | NCT06084013 | Pancreatic Carc... | Non-Interventio... | 18 Years - | OHSU Knight Cancer Institute | |
| Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Radioimmunotherapy | NCT03118349 | Pancreatic Carc... Tumors That Exp... | MVT-1075 MVT-5873 | 18 Years - | BioNTech SE | |
| A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer | NCT06168812 | Pancreatic Canc... Pancreatic Carc... Pancreatic Duct... Pancreatic Canc... Metastatic Panc... Metastatic Panc... | Glipizide | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Radioimmunotherapy | NCT03118349 | Pancreatic Carc... Tumors That Exp... | MVT-1075 MVT-5873 | 18 Years - | BioNTech SE | |
| Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial | NCT05554367 | Malignant Solid... Ovarian Low Gra... Pancreatic Carc... Stage IV Ovaria... Stage IV Pancre... | Binimetinib Biopsy Biospecimen Col... Bone Scan Computed Tomogr... Magnetic Resona... Palbociclib | 18 Years - | National Cancer Institute (NCI) | |
| Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) | NCT02676349 | Pancreatic Carc... | mFolfirinox Chemoradiothera... surgery Adjuvant chemot... | 18 Years - 75 Years | Institut de Cancérologie de Lorraine | |
| CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor | NCT02839954 | Hepatocellular ... Non-small Cell ... Pancreatic Carc... Triple-Negative... Malignant Gliom... Colorectal Carc... Gastric Carcino... | anti-MUC1 CAR-p... | 18 Years - | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | |
| Endoscopic Ultrasound (EUS) Processor Comparison | NCT01814631 | Pancreatitis Pancreatic Carc... | image quality a... image quality a... | 19 Years - 89 Years | AdventHealth | |
| Adjuvant Chemotherapy Plus Codonopsis Pilosula Nnannf /Placebo | NCT05613465 | Pancreatic Carc... Adjuvant Chemot... Cancer-related ... | Codonopsis Placebo | 18 Years - 80 Years | Zhejiang Provincial People's Hospital | |
| Phase 1b Study of CAR2Anti-CEA CAR-T Cell Hepatic Infusions for Pancreatic Carcinoma Patients With CEA+ Liver Metastases | NCT03818165 | Metastatic Panc... | CAR2 Anti-CEA C... | 18 Years - | Sorrento Therapeutics, Inc. | |
| Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) | NCT02676349 | Pancreatic Carc... | mFolfirinox Chemoradiothera... surgery Adjuvant chemot... | 18 Years - 75 Years | Institut de Cancérologie de Lorraine | |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) | NCT02465060 | Advanced Lympho... Advanced Malign... Bladder Carcino... Breast Carcinom... Cervical Carcin... Colon Carcinoma Colorectal Carc... Endometrial Car... Esophageal Carc... Gastric Carcino... Glioma Head and Neck C... Hematopoietic a... Kidney Carcinom... Liver Carcinoma Lung Carcinoma Lymphoma Malignant Uteri... Melanoma Multiple Myelom... Ovarian Carcino... Pancreatic Carc... Prostate Carcin... Rectal Carcinom... Recurrent Bladd... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Color... Recurrent Esoph... Recurrent Gastr... Recurrent Gliom... Recurrent Head ... Recurrent Liver... Recurrent Lung ... Recurrent Lymph... Recurrent Malig... Recurrent Melan... Recurrent Multi... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Skin ... Recurrent Thyro... Recurrent Uteri... Refractory Lymp... Refractory Mali... Refractory Mult... Skin Carcinoma Thyroid Gland C... Uterine Corpus ... | Adavosertib Afatinib Afatinib Dimale... Binimetinib Biopsy Biospecimen Col... Capivasertib Computed Tomogr... Copanlisib Copanlisib Hydr... Crizotinib Cytology Specim... Dabrafenib Dabrafenib Mesy... Dasatinib Defactinib Defactinib Hydr... Echocardiograph... Erdafitinib Fexagratinib Ipatasertib Laboratory Biom... Larotrectinib Larotrectinib S... Magnetic Resona... Multigated Acqu... Nivolumab Osimertinib Palbociclib Pertuzumab PI3K-beta Inhib... Radiologic Exam... Radionuclide Im... Relatlimab Sapanisertib Sunitinib Malat... Taselisib Trametinib Trastuzumab Trastuzumab Emt... Ulixertinib Vismodegib | 18 Years - | National Cancer Institute (NCI) | |
| Comparing Laparoscopic and Open Surgery for Pancreatic Carcinoma | NCT03785743 | Pancreatic Carc... Laparoscopic Pancreaticoduod... | TLPD Surgery OPD Surgery | 18 Years - 75 Years | Tongji Hospital | |
| The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer | NCT04602026 | Adult Liver Car... Gastric Carcino... Malignant Solid... Pancreatic Carc... | Best Practice Exercise Interv... Physical Therap... Questionnaire A... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy | NCT04965311 | Pancreatic Carc... | Botulinum Toxin... | 18 Years - | OHSU Knight Cancer Institute | |
| Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts | NCT06271291 | Pancreatic Carc... | Non-Interventio... | 18 Years - | Mayo Clinic | |
| Pancreatic Cancer Detection Consortium | NCT06388967 | Pancreatic Canc... Pancreatic Carc... Pancreatic Aden... Pancreatic Duct... Pancreatic Neop... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... | PANcreatic canc... | 18 Years - | City of Hope Medical Center | |
| Use Of Indocyanine Green In Pancreas Surgery | NCT06084013 | Pancreatic Carc... | Non-Interventio... | 18 Years - | OHSU Knight Cancer Institute | |
| A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients | NCT00907166 | Cancer Pancreatic Canc... Pancreatic Carc... | CPI-613 CPI-613 Gemcitabine Gemcitabine Gemcitabine | 18 Years - 70 Years | Cornerstone Pharmaceuticals | |
| Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon Cancer | NCT03137706 | Colon Carcinoma Liver and Intra... Pancreatic Carc... | Biospecimen Col... Laboratory Biom... Laboratory Proc... | 18 Years - | University of Southern California | |
| Pilot Study of Pancreatic Cancer Screening | NCT05058846 | Pancreatic Carc... | Biospecimen Col... Magnetic Resona... Magnetic Resona... Endoscopic ultr... Questionnaires | 18 Years - | University of California, San Francisco | |
| Concurrent Chemoradiotherapy Combined With Immunotherapy in Patients With Potentially Resectable Pancreatic Cancer | NCT05634564 | Pancreatic Carc... | Tislelizumab Gemcitabine Nab paclitaxel Hypofractionate... | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor | NCT02587689 | Hepatocellular ... Non-small Cell ... Pancreatic Carc... Triple-Negative... | anti-MUC1 CAR T... | 18 Years - 70 Years | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | |
| Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer | NCT00137761 | Metastatic Panc... | ZD 1839 Docetaxel | 18 Years - | Dana-Farber Cancer Institute | |
| Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1 | NCT02687230 | Pancreatic Carc... Tumors That Exp... | MVT-2163 MVT-5873 | 18 Years - | BioNTech SE | |
| Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor | NCT02587689 | Hepatocellular ... Non-small Cell ... Pancreatic Carc... Triple-Negative... | anti-MUC1 CAR T... | 18 Years - 70 Years | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | |
| A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer | NCT03899636 | Stage III Pancr... | Modified FOLFIR... NanoKnife Syste... | 18 Years - | Angiodynamics, Inc. | |
| A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up | NCT05237193 | Biliary Tract N... Pancreatic Carc... Gallbladder Can... Pancreatic Head... | The level of CI... | 18 Years - | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | |
| Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive | NCT01262040 | Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Canc... Gastrointestina... Pancreatic Carc... Lung Cancer Esophageal Carc... | Narrow Band Ima... | 19 Years - | Memorial Sloan Kettering Cancer Center | |
| The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer | NCT06115499 | Pancreatic Acin... Pancreatic Aden... Pancreatic Aden... Pancreatic Carc... Pancreatic Duct... Pancreatic Squa... Stage IV Pancre... | Nab paclitaxel Gemcitabine Cisplatin Magnetic Resona... Computed Tomogr... Biospecimen Col... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers | NCT05497531 | Hepatobiliary C... Pancreatic Canc... Hepatocellular ... Cholangiocarcin... Ampullary Cance... Pancreatic Carc... | ctDNA Blood Col... | 18 Years - | University of California, Irvine | |
| A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer | NCT03899649 | Stage III Pancr... | SOC NanoKnife Syste... | 18 Years - | Angiodynamics, Inc. | |
| Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard Chemotherapy | NCT05627427 | Neuroendocrine ... Neuroendocrine ... Pancreatic Carc... | Surufatinib Sintilimab | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues | NCT04147494 | Breast Carcinom... Colon Carcinoma Esophageal Carc... Gastric Carcino... Head and Neck C... Kidney Carcinom... Lung Carcinoma Ovarian Carcino... Pancreatic Carc... Solid Neoplasm Uterine Corpus ... | Computed Tomogr... Gallium Ga 68 F... Gallium Ga 68-l... Positron Emissi... 18F-FDG | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors | NCT03302403 | B Cell Lymphoma B Cell Leukemia Myeloma Hepatocellular ... Pancreatic Carc... Adenocarcinoma ... | CAR-CD19 T cell CAR-BCMA T cell CAR-GPC3 T cell CAR-CLD18 T cel... Fludarabine Cyclophosphamid... | 18 Years - 75 Years | First Affiliated Hospital of Wenzhou Medical University | |
| Comparing Laparoscopic and Open Surgery for Pancreatic Carcinoma | NCT03785743 | Pancreatic Carc... Laparoscopic Pancreaticoduod... | TLPD Surgery OPD Surgery | 18 Years - 75 Years | Tongji Hospital | |
| Pilot Study of Pancreatic Cancer Screening | NCT05058846 | Pancreatic Carc... | Biospecimen Col... Magnetic Resona... Magnetic Resona... Endoscopic ultr... Questionnaires | 18 Years - | University of California, San Francisco | |
| Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer | NCT04505553 | Appendix Carcin... Colon Carcinoma Esophageal Carc... Gastric Carcino... Liver and Intra... Malignant Diges... Pancreatic Carc... Rectal Carcinom... Small Intestina... Anal Carcinoma Digestive Syste... Digestive Syste... Pancreatic Neur... | Acupuncture The... Acupressure The... Oral Cryotherap... Questionnaire A... Quality-of-Life... | 18 Years - | University of Washington | |
| Comparing Two Methods to Follow Patients With Pancreatic Cysts | NCT04239573 | Pancreatic Carc... | Computed Tomogr... Endoscopic Ultr... Magnetic Resona... Quality-of-Life... Questionnaire A... | 50 Years - 75 Years | Eastern Cooperative Oncology Group | |
| A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer | NCT03899636 | Stage III Pancr... | Modified FOLFIR... NanoKnife Syste... | 18 Years - | Angiodynamics, Inc. | |
| Evaluation of 4D-contrast Enhanced PET-CT in Tumour Volume Definition | NCT02285660 | Lung Carcinoma Lower Oesophage... Pancreatic Carc... | 4D PET-CT Scan No intervention | 18 Years - 90 Years | The Leeds Teaching Hospitals NHS Trust | |
| Clinical Outcomes for Offering Genetic Testing in a Tiered Approach | NCT04902144 | Breast Carcinom... Colon Carcinoma Malignant Solid... Ovarian Carcino... Pancreatic Carc... Prostate Carcin... | Electronic Heal... Questionnaire A... Behavioral Inte... | 19 Years - 90 Years | Fred Hutchinson Cancer Center | |
| A Study of YL-17231 in Patients With Advanced Solid Tumors | NCT06078800 | Advanced Solid ... | YL-17231 | 18 Years - 75 Years | Shanghai YingLi Pharmaceutical Co. Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
